Observatory of Psychiatric Symptoms and Their Somatic Causes in Urgent Medical Care
NCT04726449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148
Last updated 2024-06-07
Summary
Use of emergency department for psychiatric symptoms always addresses the question of a potential somatic cause to the symptoms. Despite the wide-spread use of standard biology test and systematic brain imaging (for a first episode), there are still up to 5% of patients sent in psychiatric wards that actually have a somatic explanation to their symptoms which induces an important delay in the diagnostic assessement We hypothesized that simple neurological clinical examination along with fast psychometric screening tests in the Emergency Room (ER) could help the physicians to better screen the patients and thus prevent inaccurate post-emergency orientation.
Every patient visiting the ER for psychiatric symptoms will be included. The usual physical examination by the ER physician will be associated with two psychometric tests (namely the Clock-drawing test and Frontal Assessment Battery test).
The follow up will be made after 3 months in order to have the final diagnosis. Neurological data and data from the FAB test and the Clock-drawing test will be compared between patients who were finally given a psychiatric diagnosis versus patients with a somatic diagnosis at the end of the follow up period.
Conditions
- Neurologic Disorder
- Psychiatric Disorder
Interventions
- OTHER
-
Screening for acute confusional state
The intervention will consist of two psychometric test to screen for acute confusional state with the usual physical examination by the emergency physician. The neurological examination abnormalities will be noted
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
KARIM TAZAROURTE, MD, PhD · Hôpital Edouard Herriot, HCL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-11
- Primary Completion
- 2024-05-08
- Completion
- 2024-05-08
Countries
- France
Study Locations
More Related Trials
-
COVID-19 and Psychotic Symptoms in France
NCT04356885 ·Status: COMPLETED
-
Cognitive Phenotyping of Severe Psychiatric Disorders (PSYCOG)
NCT05025566 ·Status: NOT_YET_RECRUITING
-
Upside Down, Give me the Handle
NCT02544516 ·Status: COMPLETED ·Phase: NA
-
Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders
NCT07317388 ·Status: RECRUITING
-
Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist
NCT05737966 ·Status: COMPLETED
-
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
NCT04370730 ·Status: RECRUITING ·Phase: NA
-
Uppsala Psychosis Cohort
NCT05763966 ·Status: RECRUITING
-
Non-Pharmacological Treatment of Psychosis
NCT04051775 ·Status: UNKNOWN
-
Effect of Experience Sharing and Mutual Assistance on Insight and Recovery During the First Psychotic Episode
NCT06263933 ·Status: RECRUITING ·Phase: NA
-
Study of Pharmacotherapy of Psychotic Depression
NCT00056472 ·Status: COMPLETED ·Phase: PHASE3
-
A Mobile Application to Improve Case-management and Patient's Functioning in First Episode Psychosis
NCT04657380 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192 ·Status: RECRUITING ·Phase: PHASE2
-
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
NCT02321943 ·Status: COMPLETED
-
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003 ·Status: ACTIVE_NOT_RECRUITING
-
COG-PSYCHO : Social Cognition and Psychotic Characteristics: Genetic and Phenomic Approach
NCT04928053 ·Status: UNKNOWN ·Phase: NA
-
Open-Label Psilocybin Study in Transdiagnostic Population
NCT06442423 ·Status: RECRUITING ·Phase: PHASE1
-
Acute, Affective, Organic Disorders.
NCT00201474 ·Status: COMPLETED
-
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893 ·Status: COMPLETED
-
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NCT07295652 ·Status: RECRUITING ·Phase: NA
-
A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis
NCT02035553 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
NCT04874974 ·Status: COMPLETED ·Phase: NA
-
Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients
NCT02841345 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders
NCT06636474 ·Status: RECRUITING ·Phase: NA
-
CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care
NCT02933567 ·Status: COMPLETED ·Phase: NA